EMA to hold workshop on proactive release of clinical trials data
Event will address concerns from institutions, groups and individuals with a stake in the industry
A workshop on the practical and policy issues that exist around making complex drug trial data sets available to the public is being held in London, UK, on 22 November as the European Medicines Agency (EMA) prepares to begin proactive publication of clinical trials results.
The EMA-organised workshop will take into account any concerns from institutions, groups and individuals with a stake in the industry. Its results are intended to help the agency develop a strategy for providing access to clinical trial data in a way that best serves patients and public health in what EMA describes as ‘an open and transparent forum’.
Expected areas of discussion include what levels of data will be made available – aggregate, patient level etc. – and how patient confidentiality may be ensured.